Anticoagulants and antiplatelet agents in acute ischemic stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association)

Neurology

Volumn 59, Issue 1, 2002, Pages 13-22

  Coull, B M ^a   Williams, L S ^a   Goldstein, L B ^a   Meschia, J F ^a   Heitzman, D ^a   Chaturvedi, S ^a   Johnston, K C ^a   Starkman, S ^a   Morgenstern, L B ^a   Wilterdink, J L ^a   Levine, S R ^a   Saver, J L ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CERTOPARIN; DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; STREPTOKINASE;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; MEDICAL SOCIETY; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RISK BENEFIT ANALYSIS; STROKE;

EID: 0037047030     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.1.13     Document Type: Article

References (19)

1. European Stroke Initiative recommendations for stroke management
2. CAST: Randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke
3. Low molecular weight heparinoid, ORG 10172 (Dsanaparoid), and outcome after acute ischemic stroke
4. The International Stroke Trial (IST): A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke
5. Low-molecular-weight heparin for the treatment of acute ischemic stroke
6. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke
7. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke: A randomized controlled trial
8. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke
9. Abciximab in acute ischemic stroke: A randomized, double-blind, placebocontrolled, dose-escalation study
10. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: A double-blind randomised study
11. Treatment of acute ischemic stroke with the low-molecular-weight heparin certoparin. Results of the TOPAS Trial
12. Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40,000 randomized patients from the chinese acute stroke trial and the international stroke trial
13. Fraxiparine in Ischemic Stroke Study (FISS bis)
14. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
15. Anticoagulants for acute ischemic stroke (Cochrane Review)
16. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke
17. Antiplatelet therapy for acute ischemic stroke
18. Effects of ticlopidine on the neurologic outcome and the hemorheologic pattern in the postacute phase of ischemic stroke: A pilot study
19. Tinzaparin in acute ischaemic stroke (TAIST): A randomized aspirincontrolled trial